L-3-Cyanoalanine



Compound IDCDAMM02334
Common nameL-3-Cyanoalanine
IUPAC name2-amino-3-cyanopropanoic acid
Molecular formulaC4H6N2O2

Experimental data

Retention time0.56
Adduct[M+H]+
Actual mz115.051
Theoretical mz115.05
Error5.42
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.4018

Identifiers and class information

Inchi keyBXRLWGXPSRYJDZ-YEQUQEJONA-N
SmilesN#CCC(N)C(=O)O
SuperclassOrganic acids and derivatives
ClassCarboxylic acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)6
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)4
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)114.104
Computed dipole moment(dipole)10.661
Total solvent accessible surface area (SASA)295.464
Hydrophobic component of SASA (FOSA)68.901
Hydrophilic component of SASA (FISA)214.337
Pie component of the SASA (PISA)12.227
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)432.42
Number of hydrogen bond donors (donorHB)3
Number of hydrogen bond acceptors (accptHB)4.5
Free energy of solvation of dipole (dip^2/V)0.262854
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0263796
Globularity descriptor (glob)0.935973
Predicted polarizability in cubic angstroms (QPpolrz)8.7
Predicted hexadecane/gas partition coefficient (QPlogPC16)4.561
Predicted octanol/gas partition coefficient (QPlogPoct)12.845
Predicted water/gas partition coefficient (QPlogPw)9.915
Predicted octanol/water partition coefficient (QPlogPo/w)-3.421
Predicted aqueous solubility (QPlogS)-0.835
Conformation-independent predicted aqueous solubility (CIQPlogS)-0.419
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-1.545
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)5.806
Predicted brain/blood partition coefficient (QPlogBB)-0.91
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)2.665
Predicted skin permeability, log Kp (QPlogKp)-7.105
PM3 calculated ionization potential (IP(ev))10.876
PM3 calculated electron affinity (EA(eV))-0.667
Number of likely metabolic reactions (#metab)4
Prediction of binding to human serum albumin (QPlogKhsa)-1.071
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)20.588
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)99.951
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P35228NOS2Nitric oxide synthase, inducibleT02703SEA
O00222GRM8Metabotropic glutamate receptor 8T77548SEA
P43005SLC1A1Excitatory amino acid transporter 3T31721SEA
P39086GRIK1Glutamate receptor ionotropic kainate 1T73495SEA
Q13002GRIK2Glutamate receptor ionotropic kainate 2T58178SEA
O15303GRM6Metabotropic glutamate receptor 6T55956SEA
P42261GRIA1Glutamate receptor ionotropic, AMPA 1T33584SEA
Q16478GRIK5Glutamate receptor ionotropic kainate 5T87930SEA
Q13003GRIK3Glutamate receptor ionotropic kainate 3T68876SEA
P42262GRIA2Glutamate receptor ionotropic, AMPA 2T42392SEA
P07101THTyrosine 3-hydroxylaseT62390SEA
Q16719KYNUKynureninaseT99912SEA
Q07075ENPEPAminopeptidase AT31956SEA
Q01650SLC7A5L-type amino acid transporter 1 (by homology)T48330SEA
Q9UPY5SLC7A11Cystine/glutamate transporterT11615SEA
P00480OTCOrnithine transcarbamylaseT52098SEA
P42263GRIA3Glutamate receptor AMPA 3T62391SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T02703DI0083Chronic kidney disease[ICD-11: GB61]P35228NOS2
T02703DI0320Osteoarthritis[ICD-11: FA00-FA05]P35228NOS2
T02703DI0375Sepsis[ICD-11: 1G40-1G41]P35228NOS2
T02703DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P35228NOS2
T73495DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]P39086GRIK1
T73495DI0396Substance abuse[ICD-11: 6C40]P39086GRIK1
T33584DI0298Neuropathy[ICD-11: 8C0Z]P42261GRIA1
T42392DI0298Neuropathy[ICD-11: 8C0Z]P42262GRIA2
T62390DI0019Adrenomedullary hyperfunction[ICD-11: 5A75]P07101TH
T62390DI0306Nutritional deficiency[ICD-11: 5B50-5B71]P07101TH
T99912DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q16719KYNU
T99912DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q16719KYNU
T31956DI0190Hypertension[ICD-11: BA00-BA04]Q07075ENPEP
T11615DI0054Body-focused behaviour disorder[ICD-11: 6B25]Q9UPY5SLC7A11
T52098DI0258Metabolism inborn error[ICD-11: 5C50]P00480OTC
T62391DI0298Neuropathy[ICD-11: 8C0Z]P42263GRIA3

Copyright © 2025